American Fusion Inc. (OTC: AMFN) announced it has filed 19 additional U.S. patent applications covering multiple aspects of its Texatron Fusion Engine, bringing its total patent filings to 76 as the company works toward a goal of more than 260 applications. The newly filed patents span reactor architecture, plasma confinement, electromagnetic systems, fuel delivery, reactor control and power management, with the company stating the filings support continued development of the Texatron platform.
The company also reported that its engineering and operations team has begun preparations at Texas Tech University for next week's planned testing program, including installation and calibration of key testing infrastructure. Separately, American Fusion noted that scientific adviser Dr. John E. Brandenburg is scheduled to present the Texatron Fusion Engine at a conference at Fermi National Accelerator Laboratory as part of its ongoing scientific outreach efforts.
American Fusion Inc. is an advanced energy platform company focused on the development and commercialization of next-generation fusion energy technologies. The company is advancing the Texatron Fusion Engine, a neutronic fusion platform designed for modular, infrastructure-grade deployment across industrial, commercial, and grid-constrained applications. The company's development strategy emphasizes system-level engineering, disciplined intellectual property protection, and scalable architectures intended to support long-term commercial operation, while maintaining a focus on capital discipline and transparent corporate governance.
The expansion of the patent portfolio underscores American Fusion's commitment to protecting its intellectual property as it progresses toward commercialization. The company's goal of filing more than 260 applications highlights the breadth of its technology and its ambition to lead in the fusion energy sector. The upcoming testing program at Texas Tech University represents a critical step in validating the Texatron platform's performance, while Dr. Brandenburg's presentation at Fermilab aims to engage the scientific community and foster collaboration.
For more information, visit the company's newsroom at https://nnw.fm/AMFN.
